Abstract
Through exome sequencing, we identified six individuals with biallelic loss-of-function mutations in TRIP13. All six developed Wilms tumor. Constitutional mosaic aneuploidies, microcephaly, developmental delay and seizures, which are features of mosaic variegated aneuploidy (MVA) syndrome1,2, were more variably present. Through functional studies, we show that TRIP13-mutant patient cells have no detectable TRIP13 and have substantial impairment of the spindle assembly checkpoint (SAC), leading to a high rate of chromosome missegregation. Accurate segregation, as well as SAC proficiency, is rescued by restoring TRIP13 function. Individuals with biallelic TRIP13 or BUB1B mutations have a high risk of embryonal tumors3, and here we show that their cells display severe SAC impairment. MVA due to biallelic CEP57 mutations4, or of unknown cause, is not associated with embryonal tumors and cells from these individuals show minimal SAC deficiency. These data provide insights into the complex relationships between aneuploidy and carcinogenesis.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
García-Castillo, H., Vásquez-Velásquez, A.I., Rivera, H. & Barros-Núñez, P. Clinical and genetic heterogeneity in patients with mosaic variegated aneuploidy: delineation of clinical subtypes. Am. J. Med. Genet. A. 146A, 1687–1695 (2008).
Warburton, D., Anyane-Yeboa, K., Taterka, P., Yu, C.Y. & Olsen, D. Mosaic variegated aneuploidy with microcephaly: a new human mitotic mutant? Ann. Genet. 34, 287–292 (1991).
Hanks, S. et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat. Genet. 36, 1159–1161 (2004).
Snape, K. et al. Mutations in CEP57 cause mosaic variegated aneuploidy syndrome. Nat. Genet. 43, 527–529 (2011).
Ricke, R.M. & van Deursen, J.M. Aneuploidy in health, disease, and aging. J. Cell Biol. 201, 11–21 (2013).
Holland, A.J. & Cleveland, D.W. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat. Rev. Mol. Cell Biol. 10, 478–487 (2009).
Torres, E.M., Williams, B.R. & Amon, A. Aneuploidy: cells losing their balance. Genetics 179, 737–746 (2008).
Thompson, S.L., Bakhoum, S.F. & Compton, D.A. Mechanisms of chromosomal instability. Curr. Biol. 20, R285–R295 (2010).
Kajii, T. et al. Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid separation: report of five infants. Am. J. Med. Genet. 104, 57–64 (2001).
Jacquemont, S., Bocéno, M., Rival, J.M., Méchinaud, F. & David, A. High risk of malignancy in mosaic variegated aneuploidy syndrome. Am. J. Med. Genet. 109, 17–21, discussion 16 (2002).
Ruark, E. et al. OpEx—a validated, automated pipeline optimised for clinical exome sequence analysis. Sci. Rep. 6, 31029 (2016).
Mahamdallie, S.S. et al. Mutations in the transcriptional repressor REST predispose to Wilms tumor. Nat. Genet. 47, 1471–1474 (2015).
Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
Ruark, E. et al. The ICR1000 UK exome series: a resource of gene variation in an outbred population. F1000Res 4, 883 (2015).
Vader, G. Pch2TRIP13: controlling cell division through regulation of HORMA domains. Chromosoma 124, 333–339 (2015).
Eytan, E. et al. Disassembly of mitotic checkpoint complexes by the joint action of the AAA-ATPase TRIP13 and p31comet. Proc. Natl. Acad. Sci. USA 111, 12019–12024 (2014).
Ye, Q. et al. TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching. eLife 4, e07367 (2015).
Wang, K. et al. Thyroid hormone receptor interacting protein 13 (TRIP13) AAA-ATPase is a novel mitotic checkpoint–silencing protein. J. Biol. Chem. 289, 23928–23937 (2014).
Nelson, C.R., Hwang, T., Chen, P.H. & Bhalla, N. TRIP13PCH-2 promotes Mad2 localization to unattached kinetochores in the spindle checkpoint response. J. Cell Biol. 211, 503–516 (2015).
Ma, H.T. & Poon, R.Y. TRIP13 regulates both the activation and inactivation of the spindle-assembly checkpoint. Cell Rep. 14, 1086–1099 (2016).
Vleugel, M., Hoogendoorn, E., Snel, B. & Kops, G.J. Evolution and function of the mitotic checkpoint. Dev. Cell 23, 239–250 (2012).
Lunter, G. & Goodson, M. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res. 21, 936–939 (2011).
Rimmer, A. et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat. Genet. 46, 912–918 (2014).
Münz, M. et al. CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting. Genome Med. 7, 76 (2015).
Abecasis, G.R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
Gibson, D.G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009).
Drost, J. et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43–47 (2015).
Carpenter, A.E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).
Acknowledgements
We thank the families for their participation and the researchers who recruited them, including K. Asakura-Hay, S. Bernardo de Sousa, P. Callier, D. Chitayat, J. Clayton-Smith, S. Fernandes, D. FitzPatrick, L. Florentin, J. Hurst, B. Isidor, S. Jacquemont, R. Marin Iglesias, M. Micale and J. Tolmie. We thank H.J. Snippert (UMC Utrecht) for providing the lentiviral H2B plasmid. We thank A. Renwick, S. Mahamdallie, C. Loveday and members of the Kops laboratory for helpful discussions and A. Strydom and B. Rex for assistance in preparing the manuscript. We acknowledge NHS funding to the Royal Marsden/ICR NIHR Biomedical Research Centre. This research was supported by the Wellcome Trust (100210/Z/12/Z), by the Netherlands Organisation for Scientific Research (NWO-ALW 823.02.004 to G.J.P.L.K.) and by the Dutch Cancer Society (KWF Kankerbestrijding to R.M.d.V., KUN2014-6666).
Author information
Authors and Affiliations
Contributions
N.R. designed and oversaw the study. G.J.P.L.K. designed and oversaw the functional experiments. E. Ramsay undertook the exome sequencing. S.H., H.W. and S. Seal performed the molecular analyses. S.Y., M.C. and E. Ruark performed bioinformatic analyses. B.d.W., E.U., R.M.d.V., B.E. and C.M. undertook functional analyses under the supervision of G.J.P.L.K., and J.P., S.P., A.S., S. Smithson and G.H. provided samples and data, coordinated by A.Z. and A.E. S.Y., S.H., B.d.W., A.Z., G.J.P.L.K. and N.R. wrote the manuscript with input from the other authors.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–9 and Supplementary Tables 1 and 2. (PDF 8375 kb)
Rights and permissions
About this article
Cite this article
Yost, S., de Wolf, B., Hanks, S. et al. Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation. Nat Genet 49, 1148–1151 (2017). https://doi.org/10.1038/ng.3883
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3883
This article is cited by
-
Germline specific genes increase DNA double-strand break repair and radioresistance in lung adenocarcinoma cells
Cell Death & Disease (2024)
-
Identification of MAD2L1 and BUB1B as Potential Biomarkers Associated with Progression and Prognosis of Ovarian Cancer
Biochemical Genetics (2024)
-
Hallmark discoveries in the biology of Wilms tumour
Nature Reviews Urology (2024)
-
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
Communications Biology (2024)
-
Principles and dynamics of spindle assembly checkpoint signalling
Nature Reviews Molecular Cell Biology (2023)